Cite
Xu B, Tu S, Song L, et al. Angiographic quantitative flow ratio-guided coronary intervention (FAVOR III China): a multicentre, randomised, sham-controlled trial. Lancet. 2021;398(10317):2149-2159doi: 10.1016/S0140-6736(21)02248-0.
Xu, B., Tu, S., Song, L., Jin, Z., Yu, B., Fu, G., Zhou, Y., Wang, J., Chen, Y., Pu, J., Chen, L., Qu, X., Yang, J., Liu, X., Guo, L., Shen, C., Zhang, Y., Zhang, Q., Pan, H., Fu, X., Liu, J., Zhao, Y., Escaned, J., Wang, Y., Fearon, W. F., Dou, K., Kirtane, A. J., Wu, Y., Serruys, P. W., Yang, W., Wijns, W., Guan, C., Leon, M. B., Qiao, S., Stone, G. W. (2021). Angiographic quantitative flow ratio-guided coronary intervention (FAVOR III China): a multicentre, randomised, sham-controlled trial. Lancet (London, England), 398(10317), 2149-2159. https://doi.org/10.1016/S0140-6736(21)02248-0
Xu, Bo, et al. "Angiographic quantitative flow ratio-guided coronary intervention (FAVOR III China): a multicentre, randomised, sham-controlled trial." Lancet (London, England) vol. 398,10317 (2021): 2149-2159. doi: https://doi.org/10.1016/S0140-6736(21)02248-0
Xu B, Tu S, Song L, Jin Z, Yu B, Fu G, Zhou Y, Wang J, Chen Y, Pu J, Chen L, Qu X, Yang J, Liu X, Guo L, Shen C, Zhang Y, Zhang Q, Pan H, Fu X, Liu J, Zhao Y, Escaned J, Wang Y, Fearon WF, Dou K, Kirtane AJ, Wu Y, Serruys PW, Yang W, Wijns W, Guan C, Leon MB, Qiao S, Stone GW. Angiographic quantitative flow ratio-guided coronary intervention (FAVOR III China): a multicentre, randomised, sham-controlled trial. Lancet. 2021 Dec 11;398(10317):2149-2159. doi: 10.1016/S0140-6736(21)02248-0. Epub 2021 Nov 04. PMID: 34742368.
Copy
Download .nbib